24/7 Careline
Find a Doctor
> Results
Dr Vaishnavi A/P Jeyasingam
Designation:
Consultant Clinical Oncologist
Specialty:
Oncology
Qualification:
MBBS, M. CLIN (ONCO)
License Number:
MMC Registration Number: 43057, NSR Number: 132097
Languages:
English, Bahasa Melayu, Tamil
Clinic:
ParkCity Medical Centre (PMC)
Address:
No. 2, Jalan Inti Sari Perdana, Desa ParkCity, 52200 Kuala Lumpur, Kuala Lumpur, Malaysia
Conditions Treated:
- Breast
- Head And Neck
- Colorectal
- Gynaecological
- Genitourinary
- Brain
- Lung Cancers
- Pleurodesis
Procedures Performed:
- Pleural Tapping
- Peritoneal Tapping
Medical School (Undergrad):
- MBBS, University Malaya
Post-Graduate Qualifications:
- M. CLIN (ONCO), UM
Clinical Tranining:
- Clinical Attachment In Head And Neck Radiation, Princess Alexandra Hospital, Brisbane, Australia
- Clinical Attachment In Auckland City Hospital, New Zealand
Membership/Associations :
- European Society Of Medical Oncology (ESMO)
- Malaysian Oncological Society (MOS)
- Academy Of Medicine (AM)
Awards :
- Excellence of Service Award, Ministry of Health, 2016
Special Privileges According to Hospital (if any):
- IMRT, Brachytherapy
Research & Investigations:
- Site Principal Investigator for the Technical Evaluation study of treatment of Metastatic Her 2 positive Breast Cancer with Pertuzumab, Trastuzumab, and Docetaxel.
- Real world Clinical Experience of Palbociclib with Letrozole as First Line Treatment of ER positive, Her 2 negative Metastatic Breast Cancer in Malaysia. A Multicenter Retrospective Study. First author. Poster presentation in the Annual Scientific Congress Malaysian Oncological Society (ASCOMOS) 2019.
- Site Principal Investigator for the TROIKA neoadjuvant biosimilar Herceptin study in operable breast cancers. Completed recruitment.
- Site Principal Investigator for a Phase III Randomised, Double Blind Study of Pembrolizumab plus Gemcitabine/ Cisplatin versus placebo as First Line therapy in participants with Advanced and/or unresectable Biliary Tract Cancers.
- Site Principal Investigator for a Phase III Randomised Double Blind Study of Neoadjuvant Pembrolizumab/placebo plus SFU/Cisplatin vs Xeloda/Cisplatin in Resectable Gastric cancers.
- Successful spontaneous pregnancy after pelvic radiotherapy for a sacral giant cell tumour: A Case Report.
- Supervisor for Masters in Clinical Oncology thesis.Phase II Randomised Controlled Trial on Tiger Milk Mushroom (TMO 2) in patients with Breast cancer.
- Supervisor for Master in Nursing Science (UM) thesis. Effect of Low Intensity Exercise Programme on Fatigue for patients with Cancer Undergoing Chemotherapy.
- Research project on Outcomes of Advanced Gastrointestinal Stromal Tumour patients treated with Imatinib, 2013.
- Supervisor, Assessment of Adherence to Imatinib and Quality of Life among patients with Gastrointestinal Stromal Tumour in Hospital Kuala Lumpur (ADIMAQ-GIST).